Clinical characterization and founder effect analysis in Chinese amyotrophic lateral sclerosis patients with SOD1 common variants

被引:0
|
作者
Wang, Pei-Shan [1 ,2 ,3 ,4 ]
Yang, Xin-Xia [1 ,2 ,3 ,4 ]
Wei, Qiao [1 ,2 ,3 ,4 ]
Lv, Yong-Ting [1 ,2 ,3 ,4 ]
Wu, Zhi-Ying [1 ,2 ,3 ,4 ,5 ]
Li, Hong-Fu [1 ,2 ,3 ,4 ,6 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Med Genet, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Ctr Rare Dis, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[3] Zhejiang Univ, Sch Med, Dept Neurol, Hangzhou, Peoples R China
[4] Zhejiang Univ, Sch Med, Key Lab Med Neurobiol Zhejiang Prov, Hangzhou, Peoples R China
[5] Nanhu Brain Comp Interface Inst, Hangzhou, Peoples R China
[6] Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine Int, Hangzhou, Peoples R China
关键词
Amyotrophic lateral sclerosis; SOD1; Chinese; common variants; founder effect; aggregation; MOTOR-NEURON DISEASE; HIS46ARG MUTATION; TRANSGENIC MICE; H46R MUTATION; ALS; FEATURES; FAMILY; GENES; SUBSTITUTION;
D O I
10.1080/07853890.2024.2407522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In the Asian population, SOD1 variants are the most common cause of amyotrophic lateral sclerosis (ALS). To date, more than 200 variants have been reported in SOD1. This study aimed to summarize the genotype-phenotype correlation and determine whether the patients carrying common variants derive from a common ancestor. Methods: A total of 103 sporadic ALS (SALS) and 11 familial ALS (FALS) probands were included and variants were screened by whole exome sequencing. Functional analyses were performed on fibroblasts derived from patients with SOD1 p.V48A and control. Haplotype analysis was performed in the probands with p.H47R or p.V48A and their familial members. Results: A total of 25 SOD1 variants were identified in 44 probands, in which p.H47R, p.V48A and p.C112Y variants were the most common variants. 94.3% and 60% of patients with p.H47R or p.V48A had lower limb onset with predominant lower motor neurons (LMNs) involvement. Patients with p.H47R had a slow progression and prolonged survival time, while patients with p.V48A exhibited a duration of 2-5 years. Patients with p.C112Y variant showed remarkable phenotypic variation in age at onset and disease course. SOD1V48A fibroblasts showed mutant SOD1 aggregate formation, enhanced intracellular reactive oxygen species level, and decreased mitochondrial membrane potential compared to the control fibroblast. Haplotype analysis showed that seven families had two different haplotypes. p.H47R and p.V48A variants did not originate from a common founder. Conclusions: Our study expanded the understanding of the genotype-phenotype correlation of ALS with SOD1 variants and revealed that the common p.H47R or p.V48A variant did not have a founder effect.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Analysis of SOD1 variants in Chinese patients with familial amyotrophic lateral sclerosis
    Li, H.
    Yuan, L.
    Yang, H.
    Guo, Y.
    Zheng, W.
    Fan, K.
    Deng, S.
    Gong, L.
    Xu, H.
    Yang, Z.
    Cheng, J.
    Kang, M.
    Deng, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 116 (05) : 365 - 374
  • [2] Identification and functional analysis of novel mutations in the SOD1 gene in Chinese patients with amyotrophic lateral sclerosis
    Lin, Hui-Xia
    Tao, Qing-Qing
    Wei, Qiao
    Chen, Cong-Xin
    Chen, Yu-Chao
    Li, Hong-Fu
    Gitler, Aaron D.
    Wu, Zhi-Ying
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2019, 20 (3-4) : 222 - 228
  • [3] SOD1 mutations in amyotrophic lateral sclerosis
    Battistini, S
    Giannini, F
    Greco, G
    Bibbö, G
    Ferrera, L
    Marini, V
    Causarano, R
    Casula, M
    Lando, G
    Patrosso, M
    Caponnetto, C
    Origone, P
    Marocchi, A
    Del Corona, A
    Siciliano, G
    Carrera, P
    Mascia, V
    Giagheddu, M
    Carcassi, C
    Orrú, S
    Garrè, C
    Penco, S
    JOURNAL OF NEUROLOGY, 2005, 252 (07) : 782 - 788
  • [4] Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study
    Gagliardi, Delia
    Ripellino, Paolo
    Meneri, Megi
    Del Bo, Roberto
    Antognozzi, Sara
    Comi, Giacomo Pietro
    Gobbi, Claudio
    Ratti, Antonia
    Ticozzi, Nicola
    Silani, Vincenzo
    Ronchi, Dario
    Corti, Stefania
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [5] Behavioral and Cognitive Phenotypes of Patients With Amyotrophic Lateral Sclerosis Carrying SOD1 Variants
    Dalla Bella, Eleonora
    Bersano, Enrica
    Bruzzone, Maria Grazia
    Gellera, Cinzia
    Pensato, Viviana
    Lauria, Giuseppe
    Consonni, Monica
    NEUROLOGY, 2022, 99 (18) : E2052 - E2062
  • [6] Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis
    Alves Moreira, Lorenna Giannini
    Pereira, Livia Costa
    Drummond, Priscila Ramalho
    De Mesquita, Joelma Freire
    PLOS ONE, 2013, 8 (12):
  • [7] Genetic analysis and SOD1 mutation screening in Iranian amyotrophic lateral sclerosis patients
    Alavi, Afagh
    Nafissi, Shahriar
    Rohani, Mohammad
    Zamani, Babak
    Sedighi, Behnaz
    Shamshiri, Hosein
    Fan, Jian-Bing
    Ronaghi, Mostafa
    Elahi, Elahe
    NEUROBIOLOGY OF AGING, 2013, 34 (05) : 1516.e1 - 1516.e8
  • [8] Identification of an A4V SOD1 mutation in a Chinese patient with amyotrophic lateral sclerosis without the A4V founder effect common in North America
    Tang, Lu
    Ma, Yan
    Liu, Xiaolu
    Chen, Lu
    Fan, Dongsheng
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2018, 19 (5-6) : 466 - 468
  • [9] SOD1 oligomers in amyotrophic lateral sclerosis
    Choi, Esther S.
    Dokholyan, Nikolay, V
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2021, 66 : 225 - 230
  • [10] Founder effect hypothesis of D11Y SOD1 mutation in Italian amyotrophic lateral sclerosis patients
    Lattante, Serena
    Marangi, Giuseppe
    Luigetti, Marco
    Conte, Amelia
    Mandrioli, Jessica
    del Grande, Alessandra
    Zollino, Marcella
    Sabatelli, Mario
    AMYOTROPHIC LATERAL SCLEROSIS, 2012, 13 (02): : 241 - 242